Guggenheim Capital’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-10,390
| Closed | -$35K | – | 2795 |
|
|
2017
Q4 | $35K | Sell |
10,390
-1,298
| -11% | -$4.37K | ﹤0.01% | 2647 |
|
|
2017
Q3 | $25K | Sell |
11,688
-21
| -0.2% | -$45 | ﹤0.01% | 2730 |
|
|
2017
Q2 | $29K | Hold |
11,709
| – | – | ﹤0.01% | 2764 |
|
|
2017
Q1 | $27K | Buy |
11,709
+70
| +0.6% | +$161 | ﹤0.01% | 2758 |
|
|
2016
Q4 | $11K | Hold |
11,639
| – | – | ﹤0.01% | 2875 |
|
|
2016
Q3 | $13K | Buy |
+11,639
| New | +$13K | ﹤0.01% | 2857 |
|
|
2014
Q3 | – | Sell |
-11,406
| Closed | -$157K | – | 2984 |
|
|
2014
Q2 | $157K | Buy |
11,406
+883
| +8% | +$12.2K | ﹤0.01% | 2897 |
|
|
2014
Q1 | $161K | Buy |
+10,523
| New | +$161K | ﹤0.01% | 2882 |
|